We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Ultrasound Provides First Direct Evidence of Effect of Malaria on Fetal Growth

By HospiMedica International staff writers
Posted on 29 Feb 2012
A study of nearly 3,800 pregnancies has provided the most accurate and direct evidence to date that malaria infection stunts early fetal growth. More...


Low birth weight is the most significant risk factor for neonatal mortality in developing countries. The research, conducted on the border of Thailand and Myanmar, emphasizes the importance of preventing malaria in pregnancy.

According to the World Malaria Report 2011, malaria killed an estimated 655,000 people in 2010. It is caused by parasites such as Plasmodium falciparum and P. vivax, which are injected into the bloodstream by infected mosquitoes.

Malaria is one of the most common parasitic infections to affect pregnancy. Earlier studies have suggested that infection with both P. falciparum and P. vivax malaria during pregnancy reduces birth weight whether or not maternal symptoms are present. However, these studies have been hampered by difficulties in estimating gestational age accurately and diagnosing malaria infection in early pregnancy.

Now, in a study published February 9, 2012, in the open access journal PLoS One, researchers from the Shoklo Malaria Research Unit (Tak, Thailand) on the border of Thailand and Myanmar, part of the Wellcome Trust-Mahidol University-Oxford University [UK] Tropical Medicine Research Program, have utilized ultrasound scans to provide the first direct evidence of the effect of malaria on fetal growth in pregnancies.

Antenatal ultrasound, which is required for dating pregnancy accurately, is becoming more widely available in developing countries. The technology also allows doctors or locally trained workers to measure the diameter of the fetus’s head. For infections that occur in early pregnancy, the researchers believe that the size of the head may be the most appropriate indicator of growth restriction.

The ultrasound scans revealed that the diameter of the average fetus’s head was significantly smaller when malaria infection occurred in the first half of pregnancy when compared to pregnancies unaffected by malaria. On average, at the mid-pregnancy ultrasound scan the fetuses’ heads were 2% smaller when affected by malaria. Even only one infection of treated P. falciparum and P. vivax malaria was linked with reduced fetal head diameter, irrespective of whether the woman had shown symptoms or not.

However, although a single early detected and well-treated malaria episode had an effect on fetal head size at mid-trimester, this was not seen at delivery, suggesting that early treatment with effective drugs may allow for growth to recover later in pregnancy.

“By using antenatal ultrasound screening, we have provided clear evidence that malaria infection affects the growth of a child in the womb, even when the infection is caught early and treated. This can increase the risk of miscarriage and affect the child’s health in later life,” explained Dr. Marcus Rijken, first author of the study.

“Strategies to prevent malaria in pregnancy have focused on the second half of pregnancy, when most of the fetal weight gain takes place, but our works suggests that we need to broaden our efforts to focus on the first trimester, too. We need to make sure that pregnant woman are educated about the risks of malaria in pregnancy and where possible in areas of high risk, offer preventative medication from early pregnancy onwards.”

Related Links:

Shoklo Malaria Research Unit



Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Wound Irrigation Solution
Prontosan®
Gas Analyzer
GE SAM
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Surgical Techniques

view channel
Image: Memo 4D Curve preserves the mitral annulus’s natural three-dimensional motion while supporting remodeling and is available in sizes up to 42 mm for a broad range of mitral pathology. (Photo courtesy of Corcym)

First Human Implant Performed With New Open Mitral Annuloplasty Ring

In mitral valve repair, clinicians aim to preserve the mitral annulus’s three-dimensional motion while providing enough support for effective remodeling. Ring preferences vary between open and closed ... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.